» Articles » PMID: 21458401

Mutant Human Embryonic Stem Cells Reveal Neurite and Synapse Formation Defects in Type 1 Myotonic Dystrophy

Overview
Journal Cell Stem Cell
Publisher Cell Press
Specialty Cell Biology
Date 2011 Apr 5
PMID 21458401
Citations 55
Authors
Affiliations
Soon will be listed here.
Abstract

Myotonic dystrophy type 1 (DM1) is a multisystem disorder affecting a variety of organs, including the central nervous system. By using neuronal progeny derived from human embryonic stem cells carrying the causal DM1 mutation, we have identified an early developmental defect in genes involved in neurite formation and the establishment of neuromuscular connections. Differential gene expression profiling and quantitative RT-PCR revealed decreased expression of two members of the SLITRK family in DM1 neural cells and in DM1 brain biopsies. In addition, DM1 motoneuron/muscle cell cocultures showed alterations that are consistent with the known role of SLITRK genes in neurite outgrowth, neuritogenesis, and synaptogenesis. Rescue and knockdown experiments suggested that the functional defects can be directly attributed to SLITRK misexpression. These neuropathological mechanisms may be clinically significant for the functional changes in neuromuscular connections associated with DM1.

Citing Articles

From in vivo models to in vitro bioengineered neuromuscular junctions for the study of Charcot-Marie-Tooth disease.

Scherrer C, Loret C, Vedrenne N, Buckley C, Lia A, Kermene V J Tissue Eng. 2025; 16:20417314241310508.

PMID: 40078221 PMC: 11898049. DOI: 10.1177/20417314241310508.


Insight into the Association between Slitrk Protein and Neurodevelopmental and Neuropsychiatric Conditions.

Puranik N, Song M Biomolecules. 2024; 14(9).

PMID: 39334827 PMC: 11430182. DOI: 10.3390/biom14091060.


Slitrk4 is required for the development of inhibitory neurons in the fear memory circuit of the lateral amygdala.

Matsumoto Y, Miwa H, Katayama K, Watanabe A, Yamada K, Ito T Front Mol Neurosci. 2024; 17:1386924.

PMID: 38736483 PMC: 11082273. DOI: 10.3389/fnmol.2024.1386924.


Unlocking the Complexity of Neuromuscular Diseases: Insights from Human Pluripotent Stem Cell-Derived Neuromuscular Junctions.

Gazzola M, Martinat C Int J Mol Sci. 2023; 24(20).

PMID: 37894969 PMC: 10607237. DOI: 10.3390/ijms242015291.


Pluripotent Stem Cells in Disease Modeling and Drug Discovery for Myotonic Dystrophy Type 1.

Berenger-Currias N, Martinat C, Baghdoyan S Cells. 2023; 12(4).

PMID: 36831237 PMC: 9954118. DOI: 10.3390/cells12040571.